2019 American Transplant Congress
Individualized Preconditioning for ABO-Incompatible Living Donor Kidney Transplantation: An Initial Report of 48 Cases from China
*Purpose: Typically, the majority of centres that perform ABO incompatible (ABOi) kidney transplantation use fixed preconditioning protocols regardless of the initial titer. As experience in…2019 American Transplant Congress
Pushing the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death
*Purpose: Controlled donation after circulatory death (cDCD) has allowed to significantly increase the deceased donors pool. However, while excellent previous reports have been shown using…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation
Kidney Transplant, Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Recent observations suggest that the use of IVIg + rituximab has a critical role in modifying allo-reactive B-cells prior to HLAi kidney transplantation, thus…2019 American Transplant Congress
Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant
Ochsner Clinic Foundation, New Orleans, LA
*Purpose: As a consequence of natural immunosenescence, elderly patients may not require as potent immunosuppression as their younger counterparts. Optimal induction regimens in this population,…2019 American Transplant Congress
Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients
*Purpose: Secondary options for Pneumocystis Jirovecii pneumonia (PJP) prophylaxis in kidney transplant recipients (KTRs) include atovaquone or dapsone. Atovaquone use may be limited by cost/side…2019 American Transplant Congress
Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction
1Tampa General Hospital, Tampa, FL, 2Florida Kidney Physicians, Tampa, FL
*Purpose: Monoclonal antibody therapy causes profound and sustained lymphocyte depletion thus increasing the risk of viral infections. While studies exist evaluating the outcomes of alemtuzumab…2019 American Transplant Congress
Long-Term Outcomes of Elderly Living Donors: A Nationwide Population-Based Study
*Purpose: The organ shortage for kidney transplantation has increased the demand for living kidney donors, and elderly donors (> 60-years-old) have become more common. Long-term…2019 American Transplant Congress
Facilitators and Barriers to Implementing the Live Donor Champion Program
*Purpose: The Live Donor Champion (LDC) Program is an intervention designed to increase kidney transplant candidate knowledge about living donor kidney transplantation (LDKT) and ability…2019 American Transplant Congress
Correlates of Surgical Difficulty and Post-Operative Complications in Living Donor Kidney Procurement
*Purpose: Living donor kidney donation is essential for decreasing waitlists for kidney transplantation. Though donor nephrectomy is a standard operation, there is a paucity of…
- « Previous Page
- 1
- …
- 145
- 146
- 147
- 148
- 149
- …
- 214
- Next Page »